Oruka Therapeutics (NASDAQ:ORKA) Upgraded to Hold at Wall Street Zen
Wall Street Zen upgraded shares of Oruka Therapeutics (NASDAQ:ORKA – Free Report) from a sell rating to a hold rating in a report released on Sunday. Several other analysts have also issued reports on ORKA. Wedbush reissued an “outperform” rating and issued a $40.00 price target on shares of Oruka Therapeutics in a research report […]
Wall Street Zen upgraded shares of Oruka Therapeutics (NASDAQ:ORKA – Free Report) from a sell rating to a hold rating in a report released on Sunday. Several other analysts have also issued reports on ORKA. Wedbush reissued an “outperform” rating and issued a $40.00 price target on shares of Oruka Therapeutics in a research report […]
